Please see #msg-112812696, #msg-112817624, #msg-112848073, and #msg-112804827 for comments on this question. Also, bear in mind that the FDA has had MYL’s 20mg-Copaxone ANDA under review for 7.5 (!) years (#msg-41441618); if MYL truly understood how to replicate Copaxone, one would think they would have approval of the 20mg ANDA by now.
Market Data 
Markets 
AI
